Jonathan Lewis, MD, PhD

Media Releases

Where Precision Meets Impact: Pioneering Immunotherapies that Revolutionize Cancer Treatment

Dr. Jonathan Lewis has joined Syncromune as the Chief Strategy Officer, bringing his wealth of experience in cancer research and immunotherapies to lead the development of an innovative in situ platform therapy for metastatic solid tumor cancers. Syncromune, a clinical-stage biopharmaceutical company, aims to revolutionize cancer treatment with high response rates and potentially improved survival outcomes.

With a distinguished career in global translational and clinical research, Dr. Lewis has held key leadership positions at renowned biopharmaceutical companies. As the former Executive Chairman, CEO, and Chief Medical Officer of Ziopharm Oncology, he spearheaded the development of groundbreaking immunotherapies for metastatic cancers. Prior to that, he served as Chairman and Chief Medical Officer of Antigenics, Inc, focusing on personalized therapeutic vaccines for various diseases.

Dr. Lewis is a highly respected figure in the medical and scientific community, serving as Chairman of three boards and Director of two others. His educational background includes an M.D. from Witwatersrand University and a Ph.D. from Yale University, with additional training at esteemed institutions such as The Royal College of Surgeons in Edinburgh, Cambridge University, and Memorial Sloan-Kettering Cancer Center.

At Memorial Sloan-Kettering Cancer Center in New York, Dr. Lewis made significant contributions as an attending surgeon in the Department of Surgery and as an attending physician in the Clinical Immunology Service, Division of Hematologic Oncology. He also held a professorship at Weill Medical College of Cornell University, and currently serves as an Adjunct Professor at Lankenau Institute for Medical Research.

Recognized for his exceptional leadership and fundraising abilities, Dr. Lewis has raised over 1 billion US dollars in equity, nonprofit, and government funding. His achievements have been acknowledged with prestigious honors and awards in medicine and science, including the ASCO Young Investigator Award, the Kristen Carr Fellowship, the Yale University Ohse Fellowship, the Royal College of Surgeons Trubshaw Medal, the University of Cambridge Churchill Fellowship, the inaugural Kristen Ann Carr Fellowship, and the Sarcoma Foundation of America Hope and Vision Award. His extensive research has led to over 200 scientific publications and contributions to numerous textbooks in the field of cancer biology and treatment.

Syncromune is thrilled to welcome Dr. Jonathan Lewis to its team as Chief Strategy Officer, confident that his expertise and vision will drive the company towards developing innovative cancer therapies that have the potential to transform patient outcomes.

Recommended Articles

• What Is a Thyroid Biopsy?

  In a thyroid biopsy, a small tissue sample of your thyroid gland is removed and then examined under a microscope to test for an infection, cancer cells, and other thyroid disorders. The thyroid is a small gland located in lower part of the neck, just below the larynx. The gland's main function is...

• Fetal Exposure to Chemotherapy May Not Affect the Development of the Child

  A new study has given reassuring results for mothers who are under chemotherapy treatment for cancer. The study results show that fetal exposure to chemotherapy after the first trimester may not cause health problems or developmental delays in the child. In this study published in the journal...

• What is Cancer Immunotherapy?

  Immunotherapy, also referred as biological therapy, is a special type of cancer treatment aimed at boosting the body's immune system to help fight cancer cells. Cancer cells don’t die normally as other cells do, and divide uncontrollably with each cell making more of itself like a copy machine...

• Harry Connick Jr.'s Wife, Jill Goodacre, Discusses Breast Cancer Diagnosis

  A breast cancer diagnosis can come as a shock to anyone. Five years ago, Jill Goodacre Connick went in for a routine yearly check-up, and walked out with a breast cancer diagnosis.“I’ll never forget it. It was one of the hardest days of my life,” she said.She and her husband, Harry Connick...

• What Medications Are Used for Prostate Cancer?

  Prostate cancer treatments can be administered to cure cancer or to manage or alleviate its symptoms. There are several ways of treating prostate cancer and the treatment options depend on various factors such as:...

• Cholesterol Drugs Could Treat Ovarian Cancer, New Research Suggests

  What are statins?Statins are medications that are commonly used to treat low-density lipoprotein cholesterol levels in the blood. LDL cholesterol is commonly known as “bad cholesterol” and statins help to reduce its production inside the liver. More than 30% of Americans have high levels of LDL...